Evaluation of a Programming Algorithm for the Third Tachycardia Zone in a Fourth-Generation Implantable Cardioverter-Defibrillator

Journal of Interventional Cardiac Electrophysiology

Volumn 1, Issue 1, 1997, Pages 49-56

  Neglia, John J ^a,c   Krol, Ryszard B ^a   Giorgberidze, Irakli ^a   Mathew, Philip ^a   Lewis, Carolyn ^a   Munsif, Anand N ^a   Saksena, Sanjeev ^a,b,c  

^a Eastern Heart Institute   (United States)

^b Cardiac Med and Electrophysiology   (United States)

^c MEDTRONIC INC   (United States)

Author keywords

Antitachycardia pacing; Fast ventricular tachycardia zone; Implantable cardioverter defibrillator; Low energy cardioversion

Indexed keywords

AGED; ALGORITHM; ARTICLE; CARDIOVERSION; DEFIBRILLATOR; EVALUATION; FEMALE; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; MIDDLE AGED; MORTALITY; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ALGORITHMS; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EVALUATION STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME;

EID: 0031061113     PISSN: 1383875X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009766718942     Document Type: Review

References (20)

1. Mirowski M, Reid PR, Watkins L, et al. Clinical treatment of life-threatening ventricular tachyarrhythmias with the automatic implantable defibrillator. Am Heart J 1981;102:265-270.
2. Saksena S, Poczobutt-Johanos M, Castle LW, et al. for the Guardian Multicenter Investigators Group. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. J Am Coll Cardiol 1992;19:490-499.
3. Saksena, S. The PCD Investigator Group. Clinical outcome of patients with malignant ventricular tachyarrhythmias and a multiprogrammable cardioverter-defibrillator implanted with or without thoracotomy: An international multicenter study. J Am Coll Cardiol 1994;23:1521-1530.
4. Saksena S, Krol RB, Kaushik RR. Innovations in pulse generator and lead systems: Balancing complexity with clinical benefit and long-term results. Am Heart J 1994;127(Suppl): 1010-1021.
5. Jung W, Manz M, Luderitz B. New technology for implantable cardioverter-defibrillators: Capacitors, lead systems, shock waveforms. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:257-281.
6. Saksena S, Prakash A. Implantable cardioverter-defibrillators: Clinical results and patient selection. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:283-304.
7. Wyse DG, Kavanagh KM, Gillis AM. Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. Am J Cardiol 1993;71:197-202.
8. Swerdlow CD, Chen PS, Kass RM, et al. Discrimination of ventricular tachycardia from sinus tachycardia and atrial fibrillation in a tiered-therapy cardioverter-defibrillator. J Am Coll Cardiol 1994;23:1342-1355.
9. Gillberg JM, Olson WH, Bardy GH, et al. Electrogram width algorithm for discrimination of supraventricular rhythm from ventricular tachycardia (abstr). PACE 1994;17:866.
10. Lavergne T, Henry C, Ollitrault J, et al. Initial clinical experience with the first dual-chamber implantable cardioverter-defibrillator (abstr). PACE 1996;19:656.
11. Saksena S, Chandran P, Shah Y, et al. Comparative efficacy of transvenous cardioversion and pacing in patients with sustained ventricular tachycardia: A prospective, randomized, crossover study. Circulation 1985;72:153-160.
12. Bardy G, Poole J, Kudenchuk PJ, et al. A prospective randomized repeat crossover comparison of antitachycardia pacing with low energy cardioversion. Circulation 1993;87:1889-1896.
13. Saksena S, Luceri R, Krol RB, et al. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system. Am J Cardiol 1993;71:834-841.
14. Saksena S, An H, Mehra R, et al. Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992;70:304-310.
15. Fisher JD, Mehra R, Furman S. Termination of ventricular tachycardia with bursts of rapid ventricular pacing. Am J Cardiol 1978;41:94-102.
16. den Bulk K, Kersschot IE, Brugada P, et al. Is there a universal antitachycardia pacing mode? Am J Cardiol 1986;57:950-955.
17. Calvo RA, Saksena S, Pantopoulos D. Sequential transvenous pacing and shock therapy for termination of sustained ventricular tachycardia. Am Heart J 1988;115:569-575.
18. Ciccone JM, Saksena S, Shah Y, et al. A prospective randomized study of the clinical efficacy and safety of transvenous cardioversion for ventricular tachycardia termination. Circulation 1985;1:571-578.
19. Nathan AW, Bexton RS, Spurrell RA, et al. Internal transvenous low energy cardioversion for the treatment of cardiac arrhythmias. Br Heart J 1984;52:377-384.
20. Krol RB, Saksena S. Clinical trials of antiarrhythmic drugs in recipients of implantable cardioverter-defibrillators. In: Saksena S, Luderitz B, eds. Interventional Electrophysiology 1996, 2nd ed. Armonk, NY: Futura, 1996:365-375.